Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9541479 | 0.83 | TSHR (0.41) | TSHRTDP1USP2LMNACYP3A4 | |
| SCHEMBL7686788 | 0.83 | TSHR (0.41) | TSHRTDP1USP2LMNACYP3A4 | |
| SCHEMBL8221276 | 0.82 | TSHR (0.39) | TSHRTDP1LMNAMAPTSMN1; SMN2 | |
| SCHEMBL8212975 | 0.82 | TSHR (0.39) | TSHRTDP1LMNAMAPTSMN1; SMN2 | |
| SCHEMBL28773870 | 0.82 | TSHR (0.39) | TSHRTDP1LMNAMAPTSMN1; SMN2 | |
| SCHEMBL28725161 | 0.76 | TSHR (0.35) | TSHRMAPT | |
| SCHEMBL28725124 | 0.76 | GAA (0.52) | TSHRTDP1LMNAMAPTSMN1; SMN2 | |
| SCHEMBL9543095 | 0.74 | — | — | |
| SCHEMBL6053878 | 0.73 | TSHR (0.33) | TSHR | |
| SCHEMBL4444510 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1993011669-A1 | USE OF 3-PHENYLURACIL DERIVATIVES FOR THE DESICCATION AND ABSCISSION OF PLANT PARTS | BASF AKTIENGESELLSCHAFT (DE) | 1993-06-24 | — | — | WO | disclosed |